T2 Biosystems, Inc. (TTOO) financial statements (2021 and earlier)

Company profile

Business Address 101 HARTWELL AVENUE
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments42115142737474
Cash and cash equivalents17115142737474
Short-term investments25      
Restricted cash and investments      0
Receivables5320000
Inventory, net of allowances, customer advances and progress billings4431110
Inventory4431110
Other undisclosed current assets3111111
Total current assets:54195744757675
Noncurrent Assets
Operating lease, right-of-use asset113
Property, plant and equipment4671014113
Long-term investments and receivables10      
Long-term investments10      
Restricted cash and investments1000000
Other noncurrent assets0000000
Deferred tax assets, net    0
Total noncurrent assets:251081114114
TOTAL ASSETS:79286455908779
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities101577656
Accounts payable2411111
Accrued liabilities81166544
Employee-related liabilities      2
Deferred revenue00
Debt 434241140
Deferred rent credit  0
Derivative instruments and hedges, liabilities 222   
Deferred revenue and credits2320
Deferred tax liabilities    0
Contract with customer, liability1
Other undisclosed current liabilities      (2)
Total current liabilities:1061525210125
Noncurrent Liabilities
Long-term debt and lease obligation562 1402621
Long-term debt, excluding current maturities45  1402621
Operating lease, liability112
Liabilities, other than long-term debt5011120
Deferred revenue and credits1110
Deferred revenue00
Contract with customer, liability0
Deferred rent credit  0
Other liabilities3   000
Derivative instruments and hedges, liabilities1      
Total noncurrent liabilities:61212402821
Total liabilities:70625354504026
Stockholders' equity
Stockholders' equity attributable to parent9(34)111394753
Common stock0000000
Additional paid in capital432342329267243196157
Accumulated other comprehensive income0      
Accumulated deficit(423)(376)(317)(266)(204)(149)(104)
Total stockholders' equity:9(34)111394753
TOTAL LIABILITIES AND EQUITY:79286455908779

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues188115430
Revenue, net5430
Cost of revenue(21)(17)(15)(12)(7)(2) 
Cost of goods and services sold(1) (1)(12)(7)(2) 
Gross profit:(3)(8)(5)(7)(3)10
Operating expenses(39)(44)(40)(46)(48)(44)(31)
Operating loss:(41)(52)(45)(54)(51)(43)(31)
Nonoperating income (expense)(5)010000
Other nonoperating income0010000
Interest and debt expense(6)(0)  (0)(2)(1)
Loss before gain (loss) on sale of properties:(52)(52)(44)(54)(51)(45)(31)
Other undisclosed net income (loss)6(7)(7)    
Net loss:(47)(59)(51)(54)(51)(45)(31)
Other undisclosed net income (loss) attributable to parent   (9)(4)00
Net loss attributable to parent:(47)(59)(51)(62)(55)(45)(31)
Preferred stock dividends and other adjustments      (5)
Net loss available to common stockholders, diluted:(47)(59)(51)(62)(55)(45)(36)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(47)(59)(51)(54)(51)(45)(31)
Comprehensive loss:(47)(59)(51)(54)(51)(45)(31)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0   (4) 0
Comprehensive loss, net of tax, attributable to parent:(47)(59)(51)(54)(55)(45)(31)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: